SGRY vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

SGRY

36.7
AI Score
VS
SGRY Wins

PACS

34.1
AI Score

Investment Advisor Scores

SGRY

37score
Recommendation
AVOID NEW MONEY

PACS

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric SGRY PACS Winner
Forward P/E 18.9036 15.528 PACS
PEG Ratio 1.66 1.0347 PACS
Revenue Growth 2.7% 9.1% PACS
Earnings Growth 0.0% 51.6% PACS
Tradestie Score 36.7/100 34.1/100 SGRY
Profit Margin -2.6% 4.9% PACS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED PACS

Relative Price Performance (Last 90 Days)

SGRY 1M: -2.5% · 3M: +1.2% PACS 1M: +12.6% · 3M: +4.3%

Current Technical Phase

SGRY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.4 · Price: $15.40

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.6 · Price: $46.76

Fundamentals Snapshot

Metric SGRY PACS
Market Cap — —
Forward P/E 55.0 17.1
Trailing P/E — 27.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS -0.69 1.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SGRY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.